Pathways to Safer Opioid Use
Disclosure and Disclaimers
As an accredited provider of continuing education (CE) credits for the health education specialist (CHES), nursing (CNE), medicine (CME), and public health (CPH), the American Public Health Association Learning and Professional Development Programs (LPDP) unit and its respective continuing education accrediting organizations do not endorse any products or services that are displayed or referred to in conjunction with this activity and are not responsible for the actual presentation of content during scientific sessions.
There is no involvement of commercial or sponsor support for this educational activity.
Policy on Disclosures to Learners
ODPHP strives to ensure balance, independence, objectivity, and scientific rigor in all of its educational programs. All planners, faculty members, moderators, discussants, panelists, and presenters participating in this program have been required to disclose any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of this program. This includes relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is to identify openly any conflict of interest so that attendees may form their own judgments about the presentation with full disclosure of the facts. In addition, faculty is expected to openly disclose any off-label, experimental, and/or investigational uses of drugs or devices in their presentation. Disclosures, Conflict of Interest (COI) and Resolution of COI policies are available.
The following planners have no conflict of interest to disclose as it relates to this educational activity: Roger Chou, MD; COL Trinka Coster, MD, MPH; Sharon Hertz, MD; Robert Kerns, PhD; Elinore McCance-Katz, MD, PhD; Linda Porter, PhD; Briana Rider, PharmD; and David Thomas, PhD.
Resource Library Disclaimer
This training contains a Resource Library that provides hyperlinks to additional information healthcare providers can reference to help prevent opioid-related adverse drug events. The inclusion of external hyperlinks does not constitute endorsement or recommendation by the U.S. government, the U.S. Department of Health and Human Services (HHS), or the Office of the Assistant Secretary for Health of the linked training resources or the information, products, or services contained therein. HHS does not exercise any control over the content of these sites.
Disclaimer on Product Intent
This dramatization was developed by HHS in consultation with subject matter experts from various disciplines and sectors. It is intended to increase awareness of the risks of opioid-related adverse drug events (ADEs) and the opportunities for preventing such ADEs. It is not intended to reflect common clinical care.
Certain scenes demonstrate a worst-case scenario of how lapses in medical judgment, communication, and teamwork might impact patient outcomes. The intent is to provide a training tool for use by health professionals and students about patient safety concepts, rather than provide an accurate or comprehensive algorithm for treating chronic pain.
While some terminology used in this training may be considered stigmatizing or improper (e.g., addict, substance abuse, mental case, etc.), it is recognized that these terms are commonly used by the lay public. The intent of this training is for healthcare providers understand the perspective of patients living with chronic pain. ODPHP does not advocate the use of such terms by health care professionals.
This icon, , means that you are leaving health.gov and entering a non-federal website. View full disclaimer.